But-2-ynyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;2-fluoroethyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;propan-2-yl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate
C72H67F10N15O12 — CID 158931531
Data last refreshed: (MolForge compound catalog, from PubChem)
About But-2-ynyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;2-fluoroethyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;propan-2-yl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate
But-2-ynyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;2-fluoroethyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;propan-2-yl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate (PubChem CID 158931531) has the molecular formula C72H67F10N15O12 and a molecular weight of 1524.40 g/mol. Its IUPAC name is but-2-ynyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;2-fluoroethyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;propan-2-yl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | But-2-ynyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;2-fluoroethyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;propan-2-yl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 158931531 |
| Molecular Formula | C72H67F10N15O12 |
| Molecular Weight | 1524.40 g/mol |
| Exact Mass | 1523.49 |
| IUPAC Name | but-2-ynyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;2-fluoroethyl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate;propan-2-yl 4-[5-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]-2-pyridinyl]piperazine-1-carboxylate |
| SMILES | CC#CCOC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1.CC(C)OC(=O)N1CCN(c2ccc(NC(=O)c3nc(-c4ccccc4)oc3C(F)(F)F)cn2)CC1.O=C(Nc1ccc(N2CCN(C(=O)OCCF)CC2)nc1)c1nc(-c2ccccc2)oc1C(F)(F)F |
| InChI | InChI=1S/C25H22F3N5O4.C24H24F3N5O4.C23H21F4N5O4/c1-2-3-15-36-24(35)33-13-11-32(12-14-33)19-10-9-18(16-29-19)30-22(34)20-21(25(26,27)28)37-23(31-20)17-7-5-4-6-8-17;1-15(2)35-23(34)32-12-10-31(11-13-32)18-9-8-17(14-28-18)29-21(33)19-20(24(25,26)27)36-22(30-19)16-6-4-3-5-7-16;24-8-13-35-22(34)32-11-9-31(10-12-32)17-7-6-16(14-28-17)29-20(33)18-19(23(25,26)27)36-21(30-18)15-4-2-1-3-5-15/h4-10,16H,11-15H2,1H3,(H,30,34);3-9,14-15H,10-13H2,1-2H3,(H,29,33);1-7,14H,8-13H2,(H,29,33) |
| InChIKey | JJCVRHALLYHYDR-UHFFFAOYSA-N |
| XLogP | 13.20 |
| TPSA | 302.40 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 109 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1524.40 |
| LogP ≤ 5 | 13.20 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 21 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158931531 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.